The Yogen Früz Brain Project encourages Canadians to get a ”head start” on brain health

NEXT STORY
Ziopharm Oncology Names NCI’s Dr. Drew Deniger to Direct TCR-T Cell Therapy Program
PREV STORY
RedHill Biopharma Announces FDA Acceptance of New Drug Application for Talicia®
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Clinipace Worldwide Executive Joins Board of Kidney Health Initiative 

MORRISVILLE, N.C., Oct. 27, 2017 (GLOBE NEWSWIRE) -- Hampton Corley, Chief Business Officer of ...

author_avatar
NASDAQ Market News

FDA Grants INSYS Therapeutics ‘Fast Track’ Designation for Cannabidiol (CBD) Oral Solution as Investigational Treatment for Prader-Willi Syndrome

PHOENIX, Dec. 26, 2017 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), announced today that ...

author_avatar
NASDAQ Market News

Data from Prospective Phase 2 Study Investigating Delcath’s PHP Therapy presented at CIRSE 2018

Positive Results Observed in Study Endpoints Comparable to Endpoints in Delcath Registration TrialNEW YORK, ...

author_avatar
NASDAQ Market News